|
|
| | 1H-Benzimidazole,2-(ethylthio)-(9CI) Basic information |
| Product Name: | 1H-Benzimidazole,2-(ethylthio)-(9CI) | | Synonyms: | 1H-Benzimidazole,2-(ethylthio)-(9CI);2-ETHYLSULFANYL-1H-BENZOIMIDAZOLE;2-(Ethylthio)-1H-benzimidazole;Bemithyl;1H-BenziMidazole, 2-(ethylthio)-;2-ethylsulfanyl-1H-benzimidazole;Bemethyl, Bemitil, 2-ethylthiobenzimidazole hydrobromide;Bemitil | | CAS: | 14610-11-8 | | MF: | C9H10N2S | | MW: | 178.25 | | EINECS: | | | Product Categories: | BENZIMIDAZOLE | | Mol File: | 14610-11-8.mol |  |
| | 1H-Benzimidazole,2-(ethylthio)-(9CI) Chemical Properties |
| Melting point | 176 °C | | Boiling point | 352.6±25.0 °C(Predicted) | | density | 1.24±0.1 g/cm3(Predicted) | | storage temp. | -20°C Freezer, Under inert atmosphere | | solubility | Methanol (Slightly) | | form | Solid | | pka | 10.81±0.10(Predicted) | | color | Off-White |
| | 1H-Benzimidazole,2-(ethylthio)-(9CI) Usage And Synthesis |
| Uses | 2-(Ethylthio)-1H-benzimidazole is the active substance or the active ingredient in the synthesis of the drug Metaprot. Performs a transplacental function: daily administration of bemithyl (20 mg/kg) from 6 th to 16 th day of pregnancy in female rats led to the decrease in fetal death after the implantation and increased fetal body weight. |
| | 1H-Benzimidazole,2-(ethylthio)-(9CI) Preparation Products And Raw materials |
|